HealthStream Reports Record Q1 Revenue, Strong Profit Growth, Boosts Dividend, and Details Significant Share Repurchases
summarizeSummary
HealthStream announced record first-quarter revenue, significant profit growth, a 12.9% dividend increase, and $7.5 million in share repurchases, while reaffirming its full-year guidance.
check_boxKey Events
-
Record First Quarter Financial Performance
HealthStream reported record first-quarter revenues of $81.2 million, a 10.5% increase year-over-year. Operating income surged by 71.6% to $7.5 million, and net income rose 36.4% to $5.9 million, with diluted EPS reaching $0.20.
-
Significant Share Repurchases
The company repurchased 342,345 shares of common stock for an aggregate fair value of $7.5 million during the first quarter of 2026. This includes repurchases under a new $10.0 million program initiated on March 13, 2026, and the completion of a prior $10.0 million program.
-
Quarterly Dividend Increase
The Board of Directors declared a quarterly cash dividend of $0.035 per share, an increase from the previous $0.031 per share, payable on May 29, 2026.
-
Full-Year Guidance Reaffirmed
HealthStream reaffirmed its full-year 2026 guidance for revenue, net income, and Adjusted EBITDA, indicating stable expectations for continued performance.
auto_awesomeAnalysis
HealthStream delivered robust first-quarter results, achieving record revenue and substantial increases in operating and net income. The company also demonstrated strong capital allocation by increasing its quarterly dividend by 12.9% and executing significant share repurchases totaling $7.5 million in Q1, representing approximately 1.2% of its market capitalization. These actions, coupled with reaffirmed full-year guidance, signal management's confidence in the company's financial health and future prospects. The promotion of Michael M. Collier to COO further strengthens the operational leadership.
At the time of this filing, HSTM was trading at $20.71 on NASDAQ in the Technology sector, with a market capitalization of approximately $622.7M. The 52-week trading range was $19.50 to $34.13. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.